Test Efficacy Study on the Recommended Antimalarial Drugs in the Democratic Republic of the Congo

Conditions: Uncomplicated Plasmodium Falciparum Malaria Interventions: Drug: Artesunate-amodiaquine; Drug: Artemether-lumefantrine Sponsors: Ministry of Public Health, Democratic Republic of the Congo; Centers for Disease Control and Prevention; Global Fund Recruiting

https://clinicaltrials.gov/study/NCT06076213

Source: ClinicalTrials.gov - October 10, 2023 Category: Research Source Type: clinical trials